Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk (2022)
Fonte: New england journal of medicine. Unidade: FM
Assuntos: DOENÇAS CARDIOVASCULARES, FATORES DE RISCO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRADHAN, Aruna Das et al. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, v. 387, n. 21, p. 1923-1934, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50462. Acesso em: 02 nov. 2025.APA
Pradhan, A. D., Glynn, R. J., Fruchart, J. -C., Macfadyen, J. G., Zaharris, E. S., Everett, B. M., et al. (2022). Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. New england journal of medicine, 387( 21), 1923-1934. doi:10.1056/NEJMoa2210645NLM
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462Vancouver
Pradhan AD, Glynn RJ, Fruchart J-C, Macfadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk [Internet]. New england journal of medicine. 2022 ; 387( 21): 1923-1934.[citado 2025 nov. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50462
